Clinical Analysis

Our Clinical Analysis department provides an integral service in all clinical fields, from routine analysis to state-of-the-art molecular genetic tests. In order to cater for all needs,  the department features different technical units led by highly qualified specialists to give fast and accurate information that helps professional to establish the diagnosis, the monitoring and the most appropriate treatment for the patient.

In addition, our  Laboratory includes all the latest technologies, both through the constant acquisition of new analytical equipment and the implementation of new management software, enabling the unification and standardization of all processes. All this with a common goal: to work with the highest standards of quality to yield  maximum reliability and accuracy in the results.

Clinical Studies

The Clinical Studies department is a firm support for the pharmaceutical industry through its research, development and innovation work promoted by this industry. To achieve this, it has incorporated the highest quality standards in its work, achieving a high level of reliability and effectiveness.

The department is made up of four units: Phase I Clinical Trials, Phase II-IV Clinical Trials, Toxicology and Bioanalysis and Pharmaco-genetics. Their work covers most of the stages of the clinical development of a drug. Among its main fields of action, the most important are multi-centre clinical tests, with the support of the central laboratory. Other important areas are Pharmaco-genomics, which studies genetic polymorphisms, microsatellites and in vitro models; and Bioanalysis/Pharmacokinetics, which carries out quantitative analysis of drugs and their metabolites in biological matrices.

All this is done with cutting-edge technology, such as liquid chromatography linked to mass spectrometry (LC-MS/MS), qualitative and quantitative PCR in real time and all the technical and analytical facilities of the central Laboratory.


The Pathology unit focuses its activity on diagnosis through biopsy (skin, endoscopy, etc.) and pieces from surgery. This unit also includes an immune-histo-chemistry laboratory.


  • Anatomo-pathological diagnosis from biopsies and pieces from surgery
  • Gynaecological cytology
  • Diagnosis of general cytological samples (cytology from liquids, fine needle punction-aspiration of solid injuries, etc.)
  • File of preparations and histological blocks following current regulations
  • Macroscopic Photography
  • Microphotography


  • PAS
  • Grocott's silver-methenamine
  • Ziehl-Nielsen
  • Congo Red (amyloid)


  • Cell differentiation markers (cytokeratines 7, 20, Mca: 5.2,Vimentin, etc.)
  • Proliferation markers (MIB1-Ki67)
  • Oncogene products (p53, bcl2, p16,            -etc.)
  • Lymphoid markers (CD45, CD20, CD3, CD10, etc.)
  • Hormones (Inhibin, ACTH, etc.)
  • Hormone receptors
  • c-erb-B2 (Her-2-neu)
  • Infectious agents (cytomegalovirus, herpes, etc.)
  • Other markers (PSA, racemase, etc.)
  • Inmunofluorescence (Inmunoglobulins, complements, etc.)